Management of Bloodstream Infections in Left Ventricular Assist Device Recipients: To Suppress, or Not to Suppress?

BACKGROUND: Ascertaining involvement of left ventricular assist device (LVAD) in a patient presenting with bloodstream infection (BSI) can be challenging, frequently leading to use of chronic antimicrobial suppressive (CAS) therapy. We aimed to assess the efficacy of CAS therapy to prevent relapse o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Esquer Garrigos, Zerelda, Jandhyala, Deeksha, Vijayvargiya, Prakhar, Castillo Almeida, Natalia E, Gurram, Pooja, Corsini Campioli, Cristina G, Stulak, John M, Rizza, Stacey A, O’Horo, John C, DeSimone, Daniel C, Baddour, Larry M, Sohail, M Rizwan
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Major Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794653/
https://ncbi.nlm.nih.gov/pubmed/33447628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa532
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires